Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
23 September 2025 | Story Reuben Maeko | Photo Sizwe Gwiba
Dermatology Unit
Celebrating the milestone launch of the Dermatologic Surgery Unit at Universitas Academic Hospital, a new chapter for advanced patient care, training, and research.

The Department of Dermatology in the Faculty of Health Sciences at the University of the Free State (UFS) marked a historic milestone with the official opening of the Dermatologic Surgery Unit at Universitas Academic Hospital on 11 September 2025. This new facility represents a significant step forward in expanding access to specialised surgical treatment for complex dermatological conditions, while simultaneously strengthening academic training and research opportunities for registrars and medical students.

The inauguration was attended by Prof Francois P Retief, a distinguished medical pioneer from the UFS Faculty of Health Sciences, after whom one of the faculty buildings is named. His wife, Ria Retief, extended words of gratitude and gifted a book from his medical library to Prof Frans Maruma, Head of the Department of Dermatology.

“We are truly honoured to be included in this significant milestone and to witness the beginning of what we know will be an impactful journey aimed at improving patient care,” Ria Retief said. “It is a privilege to celebrate this remarkable achievement with you, and we deeply admire your dedication and vision.”

 

Honouring a legacy in dermatology

In his opening address, Prof Maruma reflected on the journey that led to the establishment of the Dermatologic Surgery Unit, acknowledging the teamwork, persistence, and collaboration that made the vision a reality.

“The Derm-Surgery Unit is not just a surgical space – it is a testament to teamwork, perseverance, and the drive to advance patient-centred care in dermatology,” he said. “We pay homage to visionary leadership that has afforded us the opportunity to expand dermatology services to include surgery and as a skill sacrosanct to modern practice. This is not only about healing, but also about preparing our registrars for the realities of clinical practice through work-integrated learning.”

Prof Maruma extended appreciation to colleagues and staff members in the Department of Dermatology, as well as strategic partners in the UFS, the Department of Health, the pharmaceutical industry, and private practitioners who dedicate their time to teaching and mentoring. Special acknowledgement was given to Dr Marc Roscher, Dr Harriet Makuru, and Dr Yashica Khalawan, who played a pivotal role in supporting the project’s launch.

The programme also included remarks by senior academic leaders. Prof Alicia Sherriff, Acting Head of the School of Clinical Medicine, commended the department for its innovation and foresight in the face of resource limitations, highlighting the potential for further expansion through collaboration with both public and private stakeholders.

While cutting the ribbon, Prof Thabiso Mofokeng, Head of Internal Medicine at Universitas Academic Hospital, emphasised that the launch of the Derm-Surgery Unit reflects the broader ethos of the clinical platform: to enable world-class training, foster research excellence, and deliver quality healthcare that is responsive to the needs of the community.

The launch underscored the university’s commitment to Work-Integrated Learning (WIL), bridging the gap between academic training and real-world clinical demands. The Derm-Surgery initiative is designed to equip registrars with essential industry-specific skills in procedural dermatology while fostering collaboration between private and public healthcare sectors. The evening concluded with awards recognising individuals whose contributions ensured the success of this landmark opening.

Looking ahead, the Department of Dermatology envisions its Derm-Surgery Unit as more than just a clinical unit – it is set to become a hub of advanced patient care, high-impact training, and cutting-edge research. This initiative strengthens the UFS Faculty of Health Sciences’ role as a leader in medical education and healthcare innovation in the Free State and beyond.

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept